Profile banner
Anthony Walker

Anthony Walker

Managing Partner at Alacrita; biotech strategy and due diligence

anthony-walker
Israel
Joined July 2026
Favicon imagealacrita.com
Favicon imagelinkedin.com
Favicon imagex.com

Network

5.1K connections

Summary

Biotech founder and early-stage CEO: Anthony has direct founding and CEO experience in biotechnology, having co-founded Onyvax and Leucid Bio and led early company formation, fundraising and the setup of research operations. lifeboat+2
Seasoned consultant and due diligence specialist: As Managing Partner at Alacrita, he focuses on strategy, technical and commercial due diligence, valuations (including rNPV and Monte Carlo approaches) and payer research for pharma and biotech clients. alacrita+2
Board and advisory experience across startups and services: He holds multiple director and advisory roles (Foothold America, HOPEC Pharma and others), supporting commercialization, US market entry and governance for life-science organizations. alacrita+2
Bridges industry and investment perspectives: His background combines management consulting at firms such as Arthur D. Little and The Wilkerson Group with practical startup leadership and venture partnering, giving him experience on both the investor and operator sides of biotech. lifeboat+2

Work

Education

Writing

Pharmaceutical Due Diligence: Checklist & Pitfalls

A white paper discussing due diligence in pharmaceutical investments, the typical pitfalls and checklist approaches for expert consulting engagements.

Favicon imagealacrita.com

Beyond rNPV Valuations

A blog post exploring limitations of rNPV valuations for pharma assets and proposing complementary approaches for assessing asset value and uncertainty.

Favicon imagealacrita.com

Hobbies

Served in a leadership role for a chamber orchestra (Strand Chamber Orchestra). gov